WAYSTAR HOLDING CORP (WAY) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:WAY • US9467841055

24.03 USD
+0.04 (+0.17%)
Last: Feb 5, 2026, 12:20 PM
Fundamental Rating

6

Taking everything into account, WAY scores 6 out of 10 in our fundamental rating. WAY was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and the financial health of WAY get a neutral evaluation. Nothing too spectacular is happening here. WAY scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make WAY a good candidate for value investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • WAY had positive earnings in the past year.
  • In the past year WAY had a positive cash flow from operations.
WAY Yearly Net Income VS EBIT VS OCF VS FCFWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

  • WAY's Return On Assets of 2.34% is amongst the best of the industry. WAY outperforms 82.86% of its industry peers.
  • The Return On Equity of WAY (3.45%) is better than 82.86% of its industry peers.
  • With a decent Return On Invested Capital value of 4.19%, WAY is doing good in the industry, outperforming 71.43% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for WAY is below the industry average of 6.63%.
  • The 3 year average ROIC (2.09%) for WAY is below the current ROIC(4.19%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.34%
ROE 3.45%
ROIC 4.19%
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
WAY Yearly ROA, ROE, ROICWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 1 -1 2 -2

1.3 Margins

  • Looking at the Profit Margin, with a value of 10.69%, WAY belongs to the top of the industry, outperforming 94.29% of the companies in the same industry.
  • Looking at the Operating Margin, with a value of 23.41%, WAY belongs to the top of the industry, outperforming 94.29% of the companies in the same industry.
  • In the last couple of years the Operating Margin of WAY has grown nicely.
  • WAY has a Gross Margin of 67.78%. This is in the better half of the industry: WAY outperforms 65.71% of its industry peers.
  • WAY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 23.41%
PM (TTM) 10.69%
GM 67.78%
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
WAY Yearly Profit, Operating, Gross MarginsWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • WAY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, WAY has more shares outstanding
  • Compared to 1 year ago, WAY has an improved debt to assets ratio.
WAY Yearly Shares OutstandingWAY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M
WAY Yearly Total Debt VS Total AssetsWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • WAY has an Altman-Z score of 2.27. This is not the best score and indicates that WAY is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of WAY (2.27) is better than 65.71% of its industry peers.
  • The Debt to FCF ratio of WAY is 4.35, which is a neutral value as it means it would take WAY, 4.35 years of fcf income to pay off all of its debts.
  • WAY has a better Debt to FCF ratio (4.35) than 65.71% of its industry peers.
  • A Debt/Equity ratio of 0.38 indicates that WAY is not too dependend on debt financing.
  • WAY has a Debt to Equity ratio of 0.38. This is in the lower half of the industry: WAY underperforms 68.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.35
Altman-Z 2.27
ROIC/WACC0.46
WACC9.15%
WAY Yearly LT Debt VS Equity VS FCFWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • WAY has a Current Ratio of 3.89. This indicates that WAY is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of WAY (3.89) is better than 80.00% of its industry peers.
  • A Quick Ratio of 3.89 indicates that WAY has no problem at all paying its short term obligations.
  • The Quick ratio of WAY (3.89) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.89
Quick Ratio 3.89
WAY Yearly Current Assets VS Current LiabilitesWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 272.54% over the past year.
  • The Revenue has grown by 14.75% in the past year. This is quite good.
  • Measured over the past years, WAY shows a quite strong growth in Revenue. The Revenue has been growing by 17.71% on average per year.
EPS 1Y (TTM)272.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%164.29%
Revenue 1Y (TTM)14.75%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%11.89%

3.2 Future

  • The Earnings Per Share is expected to grow by 52.38% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, WAY will show a quite strong growth in Revenue. The Revenue will grow by 12.62% on average per year.
EPS Next Y364.88%
EPS Next 2Y128.18%
EPS Next 3Y81.04%
EPS Next 5Y52.38%
Revenue Next Year17%
Revenue Next 2Y17.36%
Revenue Next 3Y15.05%
Revenue Next 5Y12.62%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
WAY Yearly Revenue VS EstimatesWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
WAY Yearly EPS VS EstimatesWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.93, WAY is valued on the expensive side.
  • 82.86% of the companies in the same industry are more expensive than WAY, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 28.25, WAY is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 14.55 indicates a correct valuation of WAY.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of WAY indicates a somewhat cheap valuation: WAY is cheaper than 80.00% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of WAY to the average of the S&P500 Index (27.50), we can say WAY is valued slightly cheaper.
Industry RankSector Rank
PE 17.93
Fwd PE 14.55
WAY Price Earnings VS Forward Price EarningsWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WAY indicates a somewhat cheap valuation: WAY is cheaper than 71.43% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of WAY indicates a somewhat cheap valuation: WAY is cheaper than 80.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.16
EV/EBITDA 14.17
WAY Per share dataWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • WAY has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as WAY's earnings are expected to grow with 81.04% in the coming years.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2Y128.18%
EPS Next 3Y81.04%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • WAY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

WAYSTAR HOLDING CORP

NASDAQ:WAY (2/5/2026, 12:20:40 PM)

24.03

+0.04 (+0.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)10-29
Earnings (Next)02-24
Inst Owners79.95%
Inst Owner Change-2.33%
Ins Owners1.91%
Ins Owner Change-0.23%
Market Cap4.60B
Revenue(TTM)1.04B
Net Income(TTM)111.18M
Analysts84
Price Target48.3 (101%)
Short Float %5.43%
Short Ratio3.61
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.35%
Min EPS beat(2)4.39%
Max EPS beat(2)6.31%
EPS beat(4)3
Avg EPS beat(4)28.35%
Min EPS beat(4)-1.27%
Max EPS beat(4)103.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.78%
Min Revenue beat(2)3.6%
Max Revenue beat(2)3.95%
Revenue beat(4)4
Avg Revenue beat(4)3.51%
Min Revenue beat(4)2.36%
Max Revenue beat(4)4.13%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.68%
PT rev (3m)-4.66%
EPS NQ rev (1m)-0.97%
EPS NQ rev (3m)12.32%
EPS NY rev (1m)-0.27%
EPS NY rev (3m)4.78%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)10.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.16%
Valuation
Industry RankSector Rank
PE 17.93
Fwd PE 14.55
P/S 4.42
P/FCF 16.16
P/OCF 14.94
P/B 1.43
P/tB N/A
EV/EBITDA 14.17
EPS(TTM)1.34
EY5.58%
EPS(NY)1.65
Fwd EY6.87%
FCF(TTM)1.49
FCFY6.19%
OCF(TTM)1.61
OCFY6.7%
SpS5.44
BVpS16.84
TBVpS-3.93
PEG (NY)0.05
PEG (5Y)N/A
Graham Number22.54
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 3.45%
ROCE 5.3%
ROIC 4.19%
ROICexc 4.61%
ROICexgc 99.81%
OM 23.41%
PM (TTM) 10.69%
GM 67.78%
FCFM 27.36%
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
ROICexc(3y)2.13%
ROICexc(5y)N/A
ROICexgc(3y)47.51%
ROICexgc(5y)N/A
ROCE(3y)2.64%
ROCE(5y)N/A
ROICexgc growth 3Y7.56%
ROICexgc growth 5YN/A
ROICexc growth 3Y30.65%
ROICexc growth 5YN/A
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
F-Score8
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.35
Debt/EBITDA 3.21
Cap/Depr 16.87%
Cap/Sales 2.24%
Interest Coverage 250
Cash Conversion 80.68%
Profit Quality 255.91%
Current Ratio 3.89
Quick Ratio 3.89
Altman-Z 2.27
F-Score8
WACC9.15%
ROIC/WACC0.46
Cap/Depr(3y)12.11%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.69%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)272.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%164.29%
EPS Next Y364.88%
EPS Next 2Y128.18%
EPS Next 3Y81.04%
EPS Next 5Y52.38%
Revenue 1Y (TTM)14.75%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%11.89%
Revenue Next Year17%
Revenue Next 2Y17.36%
Revenue Next 3Y15.05%
Revenue Next 5Y12.62%
EBIT growth 1Y124.84%
EBIT growth 3Y27.06%
EBIT growth 5YN/A
EBIT Next Year150.56%
EBIT Next 3Y48.39%
EBIT Next 5Y31.75%
FCF growth 1Y375.9%
FCF growth 3Y15.76%
FCF growth 5YN/A
OCF growth 1Y229.9%
OCF growth 3Y16.85%
OCF growth 5YN/A

WAYSTAR HOLDING CORP / WAY FAQ

What is the fundamental rating for WAY stock?

ChartMill assigns a fundamental rating of 6 / 10 to WAY.


What is the valuation status of WAYSTAR HOLDING CORP (WAY) stock?

ChartMill assigns a valuation rating of 7 / 10 to WAYSTAR HOLDING CORP (WAY). This can be considered as Undervalued.


Can you provide the profitability details for WAYSTAR HOLDING CORP?

WAYSTAR HOLDING CORP (WAY) has a profitability rating of 6 / 10.


How financially healthy is WAYSTAR HOLDING CORP?

The financial health rating of WAYSTAR HOLDING CORP (WAY) is 6 / 10.


What is the expected EPS growth for WAYSTAR HOLDING CORP (WAY) stock?

The Earnings per Share (EPS) of WAYSTAR HOLDING CORP (WAY) is expected to grow by 364.88% in the next year.